401 related articles for article (PubMed ID: 30457921)
1. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Stoffel EM; McKernin SE; Brand R; Canto M; Goggins M; Moravek C; Nagarajan A; Petersen GM; Simeone DM; Yurgelun M; Khorana AA
J Clin Oncol; 2019 Jan; 37(2):153-164. PubMed ID: 30457921
[TBL] [Abstract][Full Text] [Related]
2. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
3. Genetics of Familial and Sporadic Pancreatic Cancer.
Wood LD; Yurgelun MB; Goggins MG
Gastroenterology; 2019 May; 156(7):2041-2055. PubMed ID: 30660730
[TBL] [Abstract][Full Text] [Related]
4. PanGen-Fam: Spanish registry of hereditary pancreatic cancer.
Mocci E; Guillen-Ponce C; Earl J; Marquez M; Solera J; Salazar-López MT; Calcedo-Arnáiz C; Vázquez-Sequeiros E; Montans J; Muñoz-Beltrán M; Vicente-Bártulos A; González-Gordaliza C; Sanjuanbenito A; Guerrero C; Mendía E; Lisa E; Lobo E; Martínez JC; Real FX; Malats N; Carrato A
Eur J Cancer; 2015 Sep; 51(14):1911-7. PubMed ID: 26212471
[TBL] [Abstract][Full Text] [Related]
5. Genetic predisposition to pancreatic cancer.
Ghiorzo P
World J Gastroenterol; 2014 Aug; 20(31):10778-89. PubMed ID: 25152581
[TBL] [Abstract][Full Text] [Related]
6. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
7. AGA Clinical Practice Update on Colorectal and Pancreatic Cancer Risk and Screening in BRCA1 and BRCA2 Carriers: Commentary.
Kupfer SS; Gupta S; Weitzel JN; Samadder J
Gastroenterology; 2020 Aug; 159(2):760-764. PubMed ID: 32335146
[No Abstract] [Full Text] [Related]
8. Screening for pancreatic cancer in familial high-risk individuals: A systematic review.
Lu C; Xu CF; Wan XY; Zhu HT; Yu CH; Li YM
World J Gastroenterol; 2015 Jul; 21(28):8678-86. PubMed ID: 26229410
[TBL] [Abstract][Full Text] [Related]
9. Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Holter S; Borgida A; Dodd A; Grant R; Semotiuk K; Hedley D; Dhani N; Narod S; Akbari M; Moore M; Gallinger S
J Clin Oncol; 2015 Oct; 33(28):3124-9. PubMed ID: 25940717
[TBL] [Abstract][Full Text] [Related]
10. Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma.
Peters MLB; Stobie L; Dudley B; Karloski E; Allen K; Speare V; Dolinsky JS; Tian Y; DeLeonardis K; Krejdovsky J; Button A; Lim C; Borazanci E; Brand R; Tung N
Cancer; 2019 Jul; 125(14):2488-2496. PubMed ID: 30980401
[TBL] [Abstract][Full Text] [Related]
11. Familial Pancreatic Adenocarcinoma.
Petersen GM
Hematol Oncol Clin North Am; 2015 Aug; 29(4):641-53. PubMed ID: 26226902
[TBL] [Abstract][Full Text] [Related]
12. Genomics of pancreatic ductal adenocarcinoma.
Pilarsky C; Grutzmann R
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
[TBL] [Abstract][Full Text] [Related]
13. Burden of hereditary cancer susceptibility in unselected patients with pancreatic ductal adenocarcinoma referred for germline screening.
Cremin C; Lee MK; Hong Q; Hoeschen C; Mackenzie A; Dixon K; McCullum M; Nuk J; Kalloger S; Karasinska J; Scudamore C; Kim PTW; Donnellan F; Lam ECS; Lim HJ; Neben CL; Stedden W; Zhou AY; Schaeffer DF; Sun S; Renouf DJ; Schrader KA
Cancer Med; 2020 Jun; 9(11):4004-4013. PubMed ID: 32255556
[TBL] [Abstract][Full Text] [Related]
14. Familial pancreatic cancer.
Rieder H; Bartsch DK
Fam Cancer; 2004; 3(1):69-74. PubMed ID: 15131409
[TBL] [Abstract][Full Text] [Related]
15. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review.
Aslanian HR; Lee JH; Canto MI
Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142
[TBL] [Abstract][Full Text] [Related]
16. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
17. Progress report: familial pancreatic cancer.
Mintziras I; Bartsch DK
Fam Cancer; 2019 Jul; 18(3):359-362. PubMed ID: 30796632
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Pathogenic Mutations in Cancer Predisposition Genes among Pancreatic Cancer Patients.
Hu C; Hart SN; Bamlet WR; Moore RM; Nandakumar K; Eckloff BW; Lee YK; Petersen GM; McWilliams RR; Couch FJ
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):207-11. PubMed ID: 26483394
[TBL] [Abstract][Full Text] [Related]
19. The spectrum of genetic variants in hereditary pancreatic cancer includes Fanconi anemia genes.
Slavin TP; Neuhausen SL; Nehoray B; Niell-Swiller M; Solomon I; Rybak C; Blazer K; Adamson A; Yang K; Sand S; Guerrero-Llamas N; Castillo D; Herzog J; Wu X; Tao S; Raja S; Chung V; Singh G; Nadesan S; Brown S; Cruz-Correa M; Petersen GM; Weitzel J;
Fam Cancer; 2018 Apr; 17(2):235-245. PubMed ID: 28687971
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic biomarkers: could they be the answer?
Lamarca A; Feliu J
World J Gastroenterol; 2014 Jun; 20(24):7819-29. PubMed ID: 24976720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
